100 related articles for article (PubMed ID: 9089410)
1. Importance of 2-O-sulfate groups of uronate residues in heparin for activation of FGF-1 and FGF-2.
Ishihara M; Kariya Y; Kikuchi H; Minamisawa T; Yoshida K
J Biochem; 1997 Feb; 121(2):345-9. PubMed ID: 9089410
[TBL] [Abstract][Full Text] [Related]
2. Importance of 6-O-sulfate groups of glucosamine residues in heparin for activation of FGF-1 and FGF-2.
Ishihara M; Takano R; Kanda T; Hayashi K; Hara S; Kikuchi H; Yoshida K
J Biochem; 1995 Dec; 118(6):1255-60. PubMed ID: 8720143
[TBL] [Abstract][Full Text] [Related]
3. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4.
Guimond S; Maccarana M; Olwin BB; Lindahl U; Rapraeger AC
J Biol Chem; 1993 Nov; 268(32):23906-14. PubMed ID: 7693696
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2.
Ishihara M
Glycobiology; 1994 Dec; 4(6):817-24. PubMed ID: 7537556
[TBL] [Abstract][Full Text] [Related]
5. Preparation of completely 6-O-desulfated heparin and its ability to enhance activity of basic fibroblast growth factor.
Kariya Y; Kyogashima M; Suzuki K; Isomura T; Sakamoto T; Horie K; Ishihara M; Takano R; Kamei K; Hara S
J Biol Chem; 2000 Aug; 275(34):25949-58. PubMed ID: 10837484
[TBL] [Abstract][Full Text] [Related]
6. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
Krufka A; Guimond S; Rapraeger AC
Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
[TBL] [Abstract][Full Text] [Related]
7. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
Brown KJ; Hendry IA; Parish CR
J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
[TBL] [Abstract][Full Text] [Related]
8. Heparin-dependent fibroblast growth factor activities: effects of defined heparin oligosaccharides.
Zhou FY; Kan M; Owens RT; McKeehan WL; Thompson JA; Linhardt RJ; Höök M
Eur J Cell Biol; 1997 May; 73(1):71-80. PubMed ID: 9174673
[TBL] [Abstract][Full Text] [Related]
9. Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate.
Olwin BB; Rapraeger A
J Cell Biol; 1992 Aug; 118(3):631-9. PubMed ID: 1379245
[TBL] [Abstract][Full Text] [Related]
10. Is the sensitivity of cells for FGF-1 and FGF-2 regulated by cell surface heparan sulfate proteoglycans?
Zhou FY; Owens RT; Hermonen J; Jalkanen M; Höök M
Eur J Cell Biol; 1997 Jun; 73(2):166-74. PubMed ID: 9208230
[TBL] [Abstract][Full Text] [Related]
11. Structural features in heparin that interact with VEGF165 and modulate its biological activity.
Ono K; Hattori H; Takeshita S; Kurita A; Ishihara M
Glycobiology; 1999 Jul; 9(7):705-11. PubMed ID: 10362840
[TBL] [Abstract][Full Text] [Related]
12. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells.
Delehedde M; Deudon E; Boilly B; Hondermarck H
Exp Cell Res; 1996 Dec; 229(2):398-406. PubMed ID: 8986623
[TBL] [Abstract][Full Text] [Related]
13. Structural observation of complexes of FGF-2 and regioselectively desulfated heparin in aqueous solutions.
Yuguchi Y; Kominato R; Ban T; Urakawa H; Kajiwara K; Takano R; Kamei K; Hara S
Int J Biol Macromol; 2005 Mar; 35(1-2):19-25. PubMed ID: 15769511
[TBL] [Abstract][Full Text] [Related]
14. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
[TBL] [Abstract][Full Text] [Related]
15. Fluorospectrometric analysis of heparin interaction with fibroblast growth factors.
Li LY; Seddon AP
Growth Factors; 1994; 11(1):1-7. PubMed ID: 7530465
[TBL] [Abstract][Full Text] [Related]
16. Comparable stabilisation, structural changes and activities can be induced in FGF by a variety of HS and non-GAG analogues: implications for sequence-activity relationships.
Rudd TR; Uniewicz KA; Ori A; Guimond SE; Skidmore MA; Gaudesi D; Xu R; Turnbull JE; Guerrini M; Torri G; Siligardi G; Wilkinson MC; Fernig DG; Yates EA
Org Biomol Chem; 2010 Dec; 8(23):5390-7. PubMed ID: 20865198
[TBL] [Abstract][Full Text] [Related]
17. Ability of different chemically modified heparins to potentiate the biological activity of heparin-binding growth factor 1: lack of correlation with growth factor binding.
Belford DA; Hendry IA; Parish CR
Biochemistry; 1992 Jul; 31(28):6498-503. PubMed ID: 1378755
[TBL] [Abstract][Full Text] [Related]
18. Sulfated polysaccharides interact with fibroblast growth factors and protect from denaturation.
Sun C; Liu M; Sun P; Yang M; Yates EA; Guo Z; Fernig DG
FEBS Open Bio; 2019 Aug; 9(8):1477-1487. PubMed ID: 31271519
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of disaccharides derived from heparin and evaluation of effects on endothelial cell growth and on binding of heparin to FGF-2.
O'Brien A; Lynch C; O'Boyle KM; Murphy PV
Carbohydr Res; 2004 Oct; 339(14):2343-54. PubMed ID: 15388349
[TBL] [Abstract][Full Text] [Related]
20. Undersulfated and glycol-split heparins endowed with antiangiogenic activity.
Casu B; Guerrini M; Guglieri S; Naggi A; Perez M; Torri G; Cassinelli G; Ribatti D; Carminati P; Giannini G; Penco S; Pisano C; Belleri M; Rusnati M; Presta M
J Med Chem; 2004 Feb; 47(4):838-48. PubMed ID: 14761186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
